The estimated cumulative incidence of upgrade to BC of these lesions is around 30% at 25 years of follow-up, with a maximum in the first 5 years after the diagnosis [4,5] and with ADH having the highest upgrade rate to malignancy after excisional biopsy [6]. This evidence concerns the gene AVP and breast cancer.